IGF1 and Alzheimer disease: Previous studies have also shown that administering IGF-1 to mice with AD leads to the activation of the GABA system, mTOR autophagy signaling in the hippocampus, and an improvement in synaptic activity as well as a reduction in neuroinflammation [89].